penggao10

Post-IPO Simcere: Biggest American-Listed Chinese Pharma

SCR is a cash cow producing solid revenue and profit along with 30% revenue growing. As long as its gross margin remain upward over, then it will bring a good investment return over time. It needs some patience as its IPO place a price a bit higher than one thought.

Why Did Xinhua Finance Media's Singhal Suddenly Resign?

I try to shed some light based on ny research and analysis via internet. XFML is made of all bunch of stations, websites, magzines, Ads agencies that most of chinese have never heard of it. Ms. Bush spend a little money, along with finance assistacce from Singhal who had no credit in Wall Street, to make up the shell of XFML company by contracting with numerous non-profitoble stations in China virtually without audiences, valuable contents. With IPO proceeds, she then starts to acquire some others with profit to make up good-looking financial report and rapidaly grow XFML in Finance industries. She worked with Singhal to creatively name XFML company as new era of Wall Street in China to cheat those underwriters for IPOs with a name of Xinhua borrowed from Xinhua agencies though some undertable deals.The departure of Singhal is to prtect him from a accounting scandal activities during IPOs and protect his initial investment from XFML. As XFML is farely new to chinese and world, there is indeed opportunity for her to grow by allinging with other outsiters, but a risk of that is whether or not the situation could lead to a accounting fraud. My recommendation is to leave and watch until second quarters. There is more red flags than a departure of Singhal behind whole stories and more surprsing development will occurs. Sell and leave a small share for a short.
Patrick